Related Experiment Videos
Health policy uses and usefulness of cost-benefit and cost-effectiveness analysis
Mead Johnson Symposium on Perinatal and Developmental Medicine
|January 1, 1982
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The global tobacco disease pandemic: nature, causes, and cures.
Global public health·2009
Tobacco harm reduction: what do the experts think?
Tobacco control·2004
The US tobacco control community's view of the future of tobacco harm reduction.
Tobacco control·2003
Smoking prevalence in 2010: why the healthy people goal is unattainable.
American journal of public health·2000
Postnatal development of renal function.
Mead Johnson Symposium on Perinatal and Developmental Medicine·1988
Retinopathy of prematurity.
Mead Johnson Symposium on Perinatal and Developmental Medicine·1988
Prevention of respiratory distress syndrome: synergistic therapies.
Mead Johnson Symposium on Perinatal and Developmental Medicine·1988
Epidermal growth factor in the developing mammal.
Mead Johnson Symposium on Perinatal and Developmental Medicine·1988
Bridging the divide between health economics and outcomes research and biomedical investment: reflections from a health economist working in venture capital.
Journal of comparative effectiveness research·2026
Addressing the failure of economic measures of value-for-money to reflect societal preferences for health and social care.
Journal of health services research & policy·2026
Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach.
Health economics review·2026
Fever of unknown origin: cost of illness study.
Open medicine (Warsaw, Poland)·2026